SCHEMBL14824906

SCHEMBL14824906

CC(C)(O)C(C)(C)OBc1ccc(CF)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23638849 0.79 PPARG (0.33) —
SCHEMBL22924380 0.79 PDE2A (0.30) —
SCHEMBL23692800 0.74 KDM4E (0.33) —
SCHEMBL24525250 0.72 — —
SCHEMBL15894770 0.71 CYP4F2 (0.31) —
SCHEMBL24727549 0.70 TP53 (0.35) —
SCHEMBL21757902 0.70 — —
SCHEMBL17432855 0.70 LOXL2 (0.32) —
SCHEMBL25503957 0.69 RIPK1 (0.32) —
SCHEMBL23692791 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2757096-A9 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2014-11-26 — — EP disclosed
EP-2757096-A1 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2014-07-23 — — EP disclosed
EP-2574610-A1 Inhibitors of human immonodeficiency virus replication GILEAD SCIENCES, INC. (US) 2013-04-03 — — EP disclosed
Send feedback